Kriya Therapeutics raised $313 million in a significant funding round to support its pipeline of one-time gene therapies targeting ophthalmic, metabolic, and neurological diseases. This financing builds on previous rounds exceeding $500 million, underscoring investor confidence despite recent safety concerns linked to viral vectors. Develop Health secured $14.3 million to advance digital solutions for healthcare prior authorization streamlining, reflecting broader digital health investment.